Your browser is no longer supported. Please, upgrade your browser.
NVTA Invitae Corporation daily Stock Chart
Invitae Corporation
Index- P/E- EPS (ttm)-1.98 Insider Own0.90% Shs Outstand83.48M Perf Week-5.01%
Market Cap1.96B Forward P/E- EPS next Y-1.27 Insider Trans-8.84% Shs Float80.08M Perf Month-3.25%
Income-129.40M PEG- EPS next Q-0.48 Inst Own67.60% Short Float6.39% Perf Quarter63.19%
Sales147.70M P/S13.28 EPS this Y-20.90% Inst Trans-1.67% Short Ratio2.71 Perf Half Y82.74%
Book/sh2.15 P/B10.93 EPS next Y28.70% ROA-51.00% Target Price26.96 Perf Year320.39%
Cash/sh1.51 P/C15.58 EPS next 5Y8.00% ROE-88.90% 52W Range5.31 - 26.77 Perf YTD112.48%
Dividend- P/FCF- EPS past 5Y-18.20% ROI-50.00% 52W High-12.89% Beta2.20
Dividend %- Quick Ratio4.60 Sales past 5Y297.90% Gross Margin45.80% 52W Low339.17% ATR1.42
Employees788 Current Ratio4.60 Sales Q/Q78.70% Oper. Margin-82.90% RSI (14)48.94 Volatility6.80% 6.03%
OptionableYes Debt/Eq0.48 EPS Q/Q-349.10% Profit Margin-87.60% Rel Volume0.37 Prev Close23.50
ShortableYes LT Debt/Eq0.47 EarningsMay 21 AMC Payout- Avg Volume1.88M Price23.32
Recom1.70 SMA20-3.15% SMA505.55% SMA20055.92% Volume57,690 Change-0.77%
Mar-04-19Initiated Chardan Capital Markets Buy $29
Dec-19-18Initiated Oppenheimer Outperform
Nov-20-18Resumed The Benchmark Company Buy $17
Feb-13-18Reiterated The Benchmark Company Buy $11 → $10
Jan-16-18Reiterated The Benchmark Company Buy $16 → $11
Jan-16-18Reiterated Leerink Partners Outperform $12 → $10
Jan-05-18Initiated Ladenburg Thalmann Buy $15
Apr-03-17Reiterated The Benchmark Company Buy $11 → $16
Feb-14-17Upgrade The Benchmark Company Hold → Buy $8.50 → $11
Nov-10-16Resumed Leerink Partners Outperform
Jun-30-16Initiated The Benchmark Company Hold $8.50
Jan-28-16Downgrade Leerink Partners Outperform → Mkt Perform
Aug-14-15Initiated William Blair Mkt Perform
May-14-15Upgrade Leerink Partners Mkt Perform → Outperform
Apr-23-19 07:30AM  Invitae to announce first quarter 2019 financial results on May 7, 2019 PR Newswire
Apr-22-19 10:17AM  Cerner (CERN) to Report Q1 Earnings: What's in the Offing? Zacks
Apr-19-19 02:48PM  Top Gene-Sequencing Stocks for 2019 Motley Fool
Apr-18-19 03:58PM  5 Must-See Stock Charts for Monday: CGC, PINS, NVTA, UNP, BX InvestorPlace
Apr-17-19 10:03AM  What Does Invitae Corporation's (NYSE:NVTA) Balance Sheet Tell Us About It? Simply Wall St. -8.77%
Apr-09-19 03:33PM  These Cannabis and China ETFs are Leading the 2019 Rally Investopedia
Apr-07-19 09:05AM  3 High-Growth Genomics Stocks You Can Buy Motley Fool
Apr-05-19 04:04PM  5 Top Stock Trades for Monday: JD, NVTA, SBUX, SPOT, OXY InvestorPlace +5.56%
Apr-04-19 12:46PM  Why Genetic Screening Stock Invitae Skyrocketed 16.4% in March Motley Fool
Apr-02-19 07:30AM  Research Underscores Need for Updated Guidelines to Include Multigene Testing for Cancer Patients PR Newswire
Mar-29-19 08:46AM  Twilio Stock Is a Must Buy on Any Market Correction InvestorPlace
Mar-28-19 12:11PM  7 Mid-Cap Growth Stocks That Could Be the Next Amazon or Netflix InvestorPlace
09:49AM  3 Small Biotech Stocks Hitting New Highs Investopedia
Mar-27-19 01:13PM  8 Genomic Testing Stocks That Can Ease the Sting of Theranos InvestorPlace
Mar-22-19 11:39AM  Harry Boxer: 3 biotech stocks with momentum MarketWatch -8.54%
Mar-18-19 09:46AM  What Should You Know About Invitae Corporations (NYSE:NVTA) Earnings Trajectory? Simply Wall St.
12:00AM  About to Buy Penny Stocks? Look at These 3 Companies First Motley Fool
Mar-14-19 07:30AM  Invitae to Present at the Oppenheimer 29th Annual Healthcare Conference PR Newswire
Mar-12-19 06:12AM  Invitae Stock Is Hot Right Now And Heres Why It Will Only Get Hotter InvestorPlace
Mar-11-19 12:59PM  Here's Why Genetic Testing Stocks Rose as Much as 42.9% in February Motley Fool +7.92%
09:16AM  Invitae (NVTA) Scales a New 52-Week High on Solid Prospects Zacks
Mar-08-19 03:22PM  Watch CNBC's interview with Invitae CEO about genetic testing CNBC Videos
Mar-07-19 07:30AM  Recent Analysis Shows Invitae, Check Point Software Technologies, Ebix, CenturyLink, Republic Services, and Costamare Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire +5.52%
Mar-06-19 09:31PM  Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock PR Newswire
Mar-05-19 08:19PM  Invitae Announces Pricing of Public Offering of Common Stock PR Newswire
Mar-04-19 06:30PM  Today's After-Hours Moves: Salesforce and Invitae Stocks Decline Motley Fool
05:24PM  Stocks making the biggest moves after hours: Salesforce, GameStop and more CNBC
04:07PM  Invitae Announces Proposed Public Offering of Common Stock PR Newswire
Feb-26-19 07:30AM  Behind the Seizure Program Expansion Helps Speed the Diagnosis of Genetic Epilepsy in Younger Children Experiencing Unprovoked Seizures PR Newswire
Feb-25-19 07:54PM  Invitae: Buy at the High? Motley Fool
Feb-22-19 07:46AM  3 Stocks That Have Doubled, and Still Have Room to Grow Motley Fool
Feb-20-19 09:42PM  Edited Transcript of NVTA earnings conference call or presentation 19-Feb-19 9:30pm GMT Thomson Reuters StreetEvents +13.63%
04:06PM  5 Top Stock Trades for Thursday: CVS, NVTA and HSIC Earnings InvestorPlace
09:12AM  3 Small Biotechs to Watch as Earnings Season Winds Down
02:30AM  Noventa Ltd (NVTA) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-19-19 04:58PM  Invitae: 4Q Earnings Snapshot Associated Press
04:05PM  Invitae More Than Doubles Annual Volume and Revenue Year-Over-Year, Delivering 117% in Revenue Growth Driven by 102% Growth in Volume in 2018 PR Newswire
02:30PM  Invitae Corp. to Host Earnings Call ACCESSWIRE
Feb-13-19 04:06PM  5 Top Stock Trades for Thursday: NVTA, MU, NVDA, AAPL, TWLO InvestorPlace +7.56%
07:45AM  Recent Analysis Shows General Mills, Paycom Software, Invitae, Jagged Peak Energy, John B. Sanfilippo & Son, and Intrepid Potash Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
07:30AM  Invitae to Present at the 8th Annual SVB Leerink Global Healthcare Conference PR Newswire
Feb-12-19 10:30AM  Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
08:48AM  Is the Options Market Predicting a Spike in Invitae (NVTA) Stock? Zacks
07:30AM  Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information in Early Pregnancy PR Newswire
Feb-08-19 10:33PM  Here's Why Genetic Testing Stocks Rose as Much as 31.8% in January Motley Fool
10:40AM  4 Disruptive Healthcare Stocks You've Never Heard Of Motley Fool
Feb-07-19 02:52PM  How Many Insiders Sold Invitae Corporation (NYSE:NVTA) Shares? Simply Wall St.
12:00PM  New Study Finds Disease-Causing Variants More Common in Men with Prostate Cancer Than Previously Thought PR Newswire
Feb-03-19 10:19AM  3 Top Stocks That Aren't on Wall Street's Radar Motley Fool
Jan-29-19 07:30AM  Invitae to announce fourth quarter and year-end 2018 financial results on February 19, 2019 PR Newswire
Jan-07-19 11:23AM  Here's Why Invitae Gained as Much as 16% Today Motley Fool +16.44%
07:30AM  Invitae reports 2018 preliminary financial results, delivering more than 100% volume and revenue growth in 2018; projects sustained growth in expanding markets through 2019 and beyond PR Newswire
Dec-27-18 12:27PM  3 Gene Therapy Stocks to Play Biotechs Future InvestorPlace
Dec-20-18 04:31PM  Invitae to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire -9.11%
Dec-15-18 10:45AM  Do Hedge Funds Love InVitae Corporation (NVTA)? Insider Monkey
Dec-12-18 09:06AM  Here Are 3 Small-Cap Names for Biotech Investors to Consider
Dec-10-18 07:30AM  New Study Published in Journal of Clinical Oncology Supports Universal Genetic Testing for all Breast Cancer Patients PR Newswire
Dec-06-18 05:00AM  Invitae- The Second Time Around MoneyShow
Dec-04-18 08:15AM  Detailed Research: Economic Perspectives on United Technologies, Walmart, Invitae, Emergent Biosolutions, U.S. Physical Therapy, and Amdocs What Drives Growth in Today's Competitive Landscape GlobeNewswire -8.64%
Nov-16-18 04:54PM  This High-Growth Biotech Industry Is as Competitive as Ever Heading Into 2019 Motley Fool
Nov-14-18 03:27PM  Edited Transcript of NVTA earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
07:30AM  Invitae Highlighting New Research, Honoring Excellence in Genetic Counseling at National Society of Genetic Counselors (NSGC) 37th Annual Conference PR Newswire
Nov-13-18 02:48PM  It May Be Time to Buy Invitae -7.83%
Nov-08-18 03:15PM  Why Invitae Corporation Is Tanking Today Motley Fool -11.27%
Nov-07-18 08:26PM  Here's Why Invitae Lost 15.2% in October Motley Fool
06:50PM  Invitae (NVTA) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:44PM  Invitae: 3Q Earnings Snapshot Associated Press
04:05PM  Invitae Reports 106% Annual Revenue Growth Driven by 95% Annual Growth in Volume in Third Quarter 2018 PR Newswire
Oct-31-18 10:32AM  Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks +7.18%
Oct-29-18 07:30AM  Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria PR Newswire
Oct-25-18 08:30AM  Report: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +6.46%
Oct-24-18 07:30AM  Invitae to announce third quarter 2018 financial results on November 7, 2018 PR Newswire -6.00%
Oct-17-18 07:30AM  Research shows high positive rate for risk of hereditary disease in study of proactive genetic health screening for healthy people PR Newswire
Oct-11-18 07:18AM  Here's Why Invitae Jumped 13% in September Motley Fool
Sep-20-18 10:03AM  Is Invitae Corporation (NYSE:NVTA) Still A Cheap Healthcare Stock? Simply Wall St.
Sep-18-18 07:30AM  Invitae to Present at the Ladenburg Thalmann 2018 Healthcare Conference PR Newswire +10.84%
Sep-11-18 07:30AM  Invitae Appoints Chitra Nayak to its Board of Directors PR Newswire
Sep-07-18 08:44AM  Implied Volatility Surging for Invitae (NVTA) Stock Options Zacks
Sep-05-18 07:40AM  Factors of Influence in 2018, Key Indicators and Opportunity within Destination XL Group, Invitae, Federated National Holding, Bridge, QCR, and Kelly Services New Research Emphasizes Economic Growth GlobeNewswire
12:58AM  Here's Why Invitae Rose 67.5% in August Motley Fool
Aug-19-18 09:35PM  Edited Transcript of NVTA earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-16-18 08:15AM  Investor Expectations to Drive Momentum within Global Medical REIT, Cyclacel Pharmaceuticals, Super Micro Computer, Kelly Services, Invitae, and ScanSource Discovering Underlying Factors of Influence GlobeNewswire
Aug-08-18 11:40AM  Here's Why Invitae Corp Rose as Much as 20.6% Today Motley Fool +17.41%
Aug-07-18 06:50PM  Invitae (NVTA) Reports Q2 Loss, Tops Revenue Estimates Zacks
05:45PM  Invitae: 2Q Earnings Snapshot Associated Press
04:05PM  Invitae Reports More than 160% Annual Revenue Growth Driven by Nearly 140% Annual Growth in Volume in Second Quarter 2018 PR Newswire
02:30PM  Invitae Corp. to Host Earnings Call ACCESSWIRE
Aug-06-18 08:48AM  Cerner (CERN) Looks Good: Stock Adds 6.2% in Session Zacks
Jul-26-18 06:34AM  Invitae (NVTA): Moving Average Crossover Alert Zacks
Jul-24-18 07:30AM  Invitae to announce second quarter 2018 Financial Results on August 7, 2018 PR Newswire
Jul-16-18 07:20AM  Free Stock Performance Review on IQVIA Holdings and Three Additional Medical Research Stocks ACCESSWIRE
Jul-06-18 06:40AM  Here's Why Invitae Dropped 14.9% in 2018 (So Far) Motley Fool
Jun-25-18 07:30AM  Invitae Expands Reproductive Health Offering with Launch of Comprehensive Genetic Carrier Screening PR Newswire -7.30%
Jun-13-18 07:30AM  Invitae Study of 143,000 Patients Shows Importance of Routinely Including Deletion and Duplication Detection with Sequencing in Genetic Testing PR Newswire
Jun-04-18 07:10AM  Stock Performance Review on Exact Sciences and Three Other Medical Research Stocks ACCESSWIRE
May-30-18 07:30AM  Invitae to Present at the William Blair 2018 Growth Stock Conference PR Newswire
May-17-18 05:05PM  Why This Genetics Stock Could Be a Gold Mine for Growth Investors Motley Fool
May-15-18 07:52AM  Edited Transcript of NVTA earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-10-18 01:30PM  Here's Why Invitae Rose as Much as 13.9% Today Motley Fool +10.98%
May-09-18 05:19PM  Invitae: 1Q Earnings Snapshot Associated Press +5.71%
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. Its tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; and screening and testing services in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company also operates AltaVoice, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform for collecting and managing genetic family histories to deliver personalized genetic risk information. It serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stueland KatherineChief Commercial OfficerApr 16Sale25.231,00025,230185,370Apr 17 08:17 PM
Stueland KatherineChief Commercial OfficerMar 15Sale23.491,00023,490186,370Mar 19 09:24 PM
Nussbaum Robert LChief Medical OfficerMar 08Option Exercise9.9010,00099,000173,769Mar 12 07:17 PM
Guyer Shelly DChief Financial OfficerFeb 27Sale20.004,00080,018156,865Mar 01 07:24 PM
Stueland KatherineChief Commercial OfficerFeb 27Sale19.611,00019,610187,370Mar 01 07:21 PM
Dumond PattySee RemarksFeb 27Sale19.715,00098,54088,811Mar 01 07:20 PM
BENDEKGEY E LEEChief Operating OfficerFeb 26Sale19.624,65091,213173,096Feb 27 09:26 PM
Scott Randal WExecutive ChairmanFeb 25Sale19.1030,000572,9973,520,669Feb 27 02:13 PM
Dumond PattySee RemarksJan 16Sale15.003,00045,00093,811Jan 18 05:37 PM
Guyer Shelly DChief Financial OfficerJan 16Sale14.494,00057,968160,865Jan 18 05:34 PM
Stueland KatherineChief Commercial OfficerJan 15Sale13.591,00013,590188,370Jan 16 04:39 PM
Nussbaum Robert LChief Medical OfficerJan 10Sale14.015,22273,153163,769Jan 14 09:13 PM
Stueland KatherineChief Commercial OfficerDec 17Sale11.441,00011,437189,370Dec 19 08:08 PM
AGUIAR ERICDirectorNov 27Sale13.5010,000135,0000Nov 28 07:17 PM
Dumond PattySee RemarksNov 16Sale12.902,00025,80096,811Nov 20 07:46 PM
Dumond PattySee RemarksSep 20Sale16.513555,86198,811Sep 20 07:00 PM
Dumond PattySee RemarksSep 18Sale16.672904,83499,166Sep 20 07:00 PM
Stueland KatherineChief Commercial OfficerSep 09Sale13.625958,104191,963Sep 11 08:55 PM
Guyer Shelly DChief Financial OfficerMay 15Sale6.965,13535,74039,865May 16 09:11 PM
George Sean EPresident & CEOMay 15Sale6.9620,311141,365409,289May 16 09:07 PM
Nussbaum Robert LChief Medical OfficerMay 15Sale6.966,70246,64654,435May 16 09:06 PM
BENDEKGEY E LEEChief Operating OfficerMay 15Sale6.966,38844,46052,396May 16 09:02 PM
Brida ThomasGeneral CounselMay 15Sale6.961,97913,77425,973May 16 08:48 PM
Stueland KatherineChief Commercial OfficerMay 15Sale6.966,01241,84452,558May 16 08:42 PM
Dumond PattySee RemarksMay 15Sale6.965,01434,89754,456May 16 08:40 PM